6523 Stock Overview
Through its subsidiaries, offers medical devices, healthcare IT solutions, and life science products and services primarily in Japan.
Snowflake Score | |
---|---|
Valuation | 5/6 |
Future Growth | 3/6 |
Past Performance | 0/6 |
Financial Health | 4/6 |
Dividends | 3/6 |
PHC Holdings Corporation Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | JP¥1,085.00 |
52 Week High | JP¥1,549.00 |
52 Week Low | JP¥949.00 |
Beta | 0.80 |
11 Month Change | -7.19% |
3 Month Change | -7.58% |
1 Year Change | -28.90% |
33 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -59.07% |
Recent News & Updates
Shareholder Returns
6523 | JP Medical Equipment | JP Market | |
---|---|---|---|
7D | 0.7% | 3.0% | 3.7% |
1Y | -28.9% | 27.4% | 14.4% |
Return vs Industry: 6523 underperformed the JP Medical Equipment industry which returned 27.4% over the past year.
Return vs Market: 6523 underperformed the JP Market which returned 14.4% over the past year.
Price Volatility
6523 volatility | |
---|---|
6523 Average Weekly Movement | 5.7% |
Medical Equipment Industry Average Movement | 6.0% |
Market Average Movement | 6.5% |
10% most volatile stocks in JP Market | 10.4% |
10% least volatile stocks in JP Market | 3.5% |
Stable Share Price: 6523 has not had significant price volatility in the past 3 months.
Volatility Over Time: 6523's weekly volatility (6%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2013 | 9,245 | Kay Deguchi | phchd.com |
PHC Holdings Corporation, through its subsidiaries, offers medical devices, healthcare IT solutions, and life science products and services primarily in Japan. It operates through Diabetes Management, Healthcare Solutions, and Diagnostic & Life Sciences segments. The company offers blood glucose monitoring systems, continuous glucose monitoring systems, and diabetes application; patient and record billing software, including electronic medical record system, electronic medication history system, and healthcare note service; and diagnostic testing products, which include clinical testing, diagnostic reagents and instruments, and drug development support products.
PHC Holdings Corporation Fundamentals Summary
6523 fundamental statistics | |
---|---|
Market cap | JP¥139.86b |
Earnings (TTM) | -JP¥12.87b |
Revenue (TTM) | JP¥357.76b |
0.4x
P/S Ratio-10.6x
P/E RatioIs 6523 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
6523 income statement (TTM) | |
---|---|
Revenue | JP¥357.76b |
Cost of Revenue | JP¥199.02b |
Gross Profit | JP¥158.74b |
Other Expenses | JP¥171.61b |
Earnings | -JP¥12.87b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Nov 13, 2024
Earnings per share (EPS) | -102.02 |
Gross Margin | 44.37% |
Net Profit Margin | -3.60% |
Debt/Equity Ratio | 189.5% |
How did 6523 perform over the long term?
See historical performance and comparisonDividends
3.9%
Current Dividend Yield-53%
Payout RatioDoes 6523 pay a reliable dividends?
See 6523 dividend history and benchmarksPHC Holdings dividend dates | |
---|---|
Ex Dividend Date | Sep 27 2024 |
Dividend Pay Date | Dec 04 2024 |
Days until Ex dividend | 0 days |
Days until Dividend pay date | 68 days |
Does 6523 pay a reliable dividends?
See 6523 dividend history and benchmarks